James L Tyree insider trades

Open-market stock purchases and sales by James L Tyree, Director at GENELUX Corp, from SEC Form 4 filings since Jun 5, 2012.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -44%.

Recent trades

DateStockTradeValue
Jun 16, 2026GNLX GENELUX CorpBought (not open market)—
Jun 16, 2026GNLX GENELUX CorpBought (not open market)—

Companies traded

  • GNLX GENELUX Corp: 1 buy, 4 sales, last Jun 16, 2026
  • ASRT Assertio Holdings, Inc: 3 sales, last Mar 14, 2024
  • CCXI ChemoCentryx, Inc: 11 sales, last Oct 20, 2022
  • DEPO Depomed Inc: other filings, last May 8, 2018
  • INVA Innoviva, Inc: 1 sale, last Apr 20, 2017
  • THRX Theravance Inc: 1 sale, last Jun 2, 2015

Get free alerts when James L Tyree files a new trade →